Status:

COMPLETED

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

Lead Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborating Sponsors:

H. Lundbeck A/S

Conditions:

Agitation Associated With Alzheimer's Disease

Alzheimer's Type

Eligibility:

All Genders

Brief Summary

To follow-up on the safety of subjects who were previously treated in a double-blind trial of brexpiprazole.

Detailed Description

Behavioral symptoms, such as agitation, are core features in subjects with Alzheimer's disease and related dementias, and develop in the majority of dementia subjects. The presence of agitation in sub...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • The investigator must assess the capacity of the subject to provide informed consent prior to enrollment and throughout the trial.
  • Male and female subjects who completed both the 12-week double-blind treatment period and the 30-day safety follow-up visit of the previous brexpiprazole trial.
  • Subject has an identified caregiver who is usually assigned to care for the subject on a regular basis, has sufficient contact to describe the subject's symptoms, and has direct observation of the subject's behavior.
  • Subject is able to comply with the protocol requirements.
  • Exclusion Criterion:
  • Subjects who, in the opinion of the investigator, medical monitor, or sponsor should not participate in the trial.

Exclusion

    Key Trial Info

    Start Date :

    June 1 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2017

    Estimated Enrollment :

    450 Patients enrolled

    Trial Details

    Trial ID

    NCT02192554

    Start Date

    June 1 2014

    End Date

    May 1 2017

    Last Update

    April 30 2018

    Active Locations (84)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 21 (84 locations)

    1

    Tuscaloosa, Alabama, United States, 35404

    2

    Costa Mesa, California, United States, 92626

    3

    Lakewood, California, United States, 90805

    4

    Orange, California, United States, 92868